Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← Analysis & Perspectives
Health Management AssociatesJanuary 8, 2026

Federal Drug Pricing Overhaul Could Reshape Medicaid Pharmacy Spending

HMA reviews new executive branch efforts to lower drug costs through "most favored nation" pricing benchmarks, including confidential manufacturer agreements and new CMS Innovation Center models. The analysis notes that these MFN agreements are expected to give state Medicaid programs access to discounted pricing and require new drugs to launch domestically at internationally aligned prices, which has direct implications for Medicaid pharmacy budgets and state drug procurement strategies.

Pharmacy · Finance

Read the full analysis at Health Management Associates →

This is outside commentary from Health Management Associates, not part of Medicaid Monitor's independently scored news coverage.

Share this

More from Health Management Associates

← Analysis & Perspectives

Get the daily briefing.